M James Frates

Affiliations

  • Chief Financial Officer at Amylyx Pharmaceuticals Inc. (AMLX), 2024-09-16
  • at Sage Therapeutics Inc. (SAGE), 2024-06-11
  • Svp, Alks Inc; Cfo Alks at Alkermes Plc. (ALKS), 2020-05-14
  • Svp, Cfo & Treasurer at Alkermes Inc (ALKS), 2011-09-20
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AMLX $2.53 40,000 233,464 2024-09-12 Filing
SAGE $55.10 1,810 1,810 2021-06-16 Filing
SAGE $18.00 5,000 Director 5,000 2014-07-23 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AMLX $18.73 1,792 134,784 2024-03-05 Filing
AMLX $16.33 2,716 112,035 2024-01-09 Filing
AMLX $27.60 500 Officer 55,676 2023-05-16 Filing
AMLX $26.93 32,000 Officer 56,176 2023-05-16 Filing
AMLX $32.46 1,704 Officer 34,009 2023-03-16 Filing